Herbs (Global Traditional) · European
Meadowsweet (Filipendula ulmaria) (Filipendula ulmaria)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Meadowsweet (Filipendula ulmaria) contains salicylates and flavonoids that inhibit cyclooxygenase enzymes, providing anti-inflammatory effects. In vitro studies show 32-63% COX-1 inhibition and 20-46% COX-2 inhibition at 50 µg/mL concentrations.
Meadowsweet (Filipendula ulmaria) is a perennial herb native to Europe and temperate Asia, traditionally harvested from its aerial parts (flowers and leaves) and roots. Extracts are commonly prepared through methanolic extraction, decoction, or dry tincture methods, yielding preparations rich in polyphenolic compounds, particularly flavonoids and tannins.
Evidence for meadowsweet is limited to animal and in vitro studies, with no human clinical trials identified. Key research includes a 16-month rat chemoprevention study (n=103) showing tumor reduction, and anti-inflammatory studies in rat models demonstrating effects comparable to indomethacin. While one human RCT examined a combination beverage containing meadowsweet with chamomile and willow bark, meadowsweet-specific results were not reported.
Animal studies used flower decoction at 1 g/kg body weight daily for chemoprevention, and methanolic extracts from aerial parts or roots at 100-200 mg/kg body weight for anti-inflammatory effects. No human dosage data or standardization information is available from clinical studies. Consult a healthcare provider before starting any new supplement.
Meadowsweet (Filipendula ulmaria) is a medicinal herb consumed primarily as a tea or tincture, not as a food staple, so macronutrient intake is negligible in typical use. Key bioactive compounds drive its nutritional and therapeutic profile: Phenolic compounds are the dominant class, with total phenolic content measured at approximately 50–150 mg gallic acid equivalents (GAE)/g dry weight depending on plant part (flowers > leaves > stems). Salicylates: spiraein (salicylaldehyde glycoside) and monotropitin (methyl salicylate glycoside) are characteristic compounds at approximately 0.5–1.0% of dry flower weight, serving as natural precursors to salicylic acid — the basis for aspirin's original development from this plant. Flavonoids: quercetin, kaempferol, and their glycosides (spireoside/quercetin-4'-glucoside) are present at approximately 2–4% of dry flower weight; rutin is present at roughly 1–2% dry weight. Tannins: hydrolyzable tannins (ellagitannins) and condensed tannins at approximately 10–15% dry weight in aerial parts, contributing astringent properties. Phenolic acids: salicylic acid (~0.1–0.5 mg/g dry weight), ellagic acid, and caffeic acid derivatives. Essential oils: approximately 0.2–0.5% of fresh flower weight, containing salicylaldehyde (dominant, ~40–60% of volatile fraction), methyl salicylate, and benzaldehyde. Vitamin C: present in fresh plant material at approximately 150–200 mg/100g fresh weight (flowers), though degraded with drying and infusion preparation. Mineral content: moderate potassium (~300–400 mg/100g dry herb), calcium (~200–300 mg/100g), and magnesium (~50–80 mg/100g) based on comparable herbal analyses; iron and manganese present in trace amounts. Fiber: significant in whole plant material (~15–25% dry weight as structural carbohydrates), but not physiologically relevant in infusion/tincture form. Bioavailability notes: Salicylate glycosides require hydrolysis by gut microbiota or gastric acid to release active aglycones; bioavailability is estimated at 30–60% relative to free salicylic acid. Flavonoid glycosides undergo intestinal deglycosylation prior to absorption; quercetin bioavailability from glycoside forms is approximately 30–52% in human studies with comparable plant matrices. High tannin content may reduce absorption of iron and other minerals when consumed alongside meals. Polyphenols exhibit antioxidant activity with DPPH radical scavenging IC50 values reported at approximately 10–30 µg/mL for flower extracts.
Meadowsweet's salicylates, particularly methyl salicylate and salicylic acid, inhibit cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis and inflammatory responses. The flavonoids quercetin and kaempferol provide additional antioxidant activity by scavenging free radicals and modulating inflammatory cytokines. This dual mechanism creates synergistic anti-inflammatory effects similar to aspirin but with potentially fewer gastric side effects.
In vitro studies demonstrate meadowsweet extract inhibits COX-1 by 32-63% and COX-2 by 20-46% at 50 µg/mL concentrations. Preliminary rat studies show significant reduction in paw edema comparable to indomethacin, indicating strong anti-inflammatory potential. Cancer prevention research in rats showed 1.5-fold reduction in overall malignancy markers, though this data appears incomplete. Most evidence remains preclinical, with limited human trials available to confirm therapeutic efficacy and optimal dosing protocols.
Meadowsweet contains natural salicylates and may cause adverse reactions in individuals with salicylate sensitivity or aspirin allergies. It may enhance anticoagulant effects when combined with warfarin or other blood-thinning medications due to salicylate content. Gastrointestinal irritation, though reportedly less common than with synthetic salicylates, may still occur with high doses. Pregnancy and breastfeeding safety data is insufficient, and use should be avoided during these periods.
